NEW YORK (360Dx) – Genesis Biotechnology Group announced today that it has acquired the assets of 4path, an Illinois-based anatomic and clinical pathology lab.

According to Genesis, the acquisition is expected to expand the reach of its diagnostics branch — which includes Hamilton, New Jersey-based Medical Diagnostic Laboratories — and allow it to establish a rapid response clinical lab in the Midwest.

Specific terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.